CSPC Pharma (1093 HK): AstraZeneca Collaboration Good, Impact Might Be Short Lived Given Competition
​CSPC Pharma partnered with AstraZeneca for long-acting peptide medicines, receiving substantial upfront and milestone payments. Weight loss drug...
276 Views
Alteogen: 2nd Largest Shareholder Raises Stake & Requests Switching Listing from KOSDAQ to KOSPI
Alteogen announced that it will hold an EGM on 8 December to vote on a transfer of listing to KOSPI from KOSDAQ. On 7 July, the second largest...
667 Views
Eccogene (诚益生物) Pre-IPO: Decent Innovation and Differentiation
​China's Eccogene aims to raise $100 million through Hong Kong listing. We see decent innovation and differentiation in its assets.
588 Views
Impact Therapeutics (英派药业) Pre-IPO: Credible R&D in PARP
​China's Impact Therapeutics seeks to raise $100 million through Hong Kong listing with GS and CICC as joint sponsors. We look at the fundamental...
551 Views
Primer: AstraZeneca PLC (AZN LN) - Sep 2025
AstraZeneca is a global biopharmaceutical powerhouse, strongly positioned for sustained growth driven by its leadership in Oncology and...
141 Views